Press Release|Articles|July 30, 2025
Camber Launches Prucalopride Tablets
Listen
0:00 / 0:00
Key Takeaways
- Camber Pharmaceuticals introduces Prucalopride Tablets, a generic for Motegrity®, targeting chronic idiopathic constipation in adults.
- Chronic idiopathic constipation affects 10-17% of the global population, predominantly women and older adults.
Advertisement
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Prucalopride Tablets [proo-KAL-oh-pride] to its growing portfolio. Prucalopride Tablets are generic for Motegrity®.
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. CIC affects about 10-17% of the global population and is more commonly seen in women and older adults.
Prucalopride Tablets are available in 1 mg and 2 mg strengths in 30 count bottles.
To learn more about Prucalopride Tablets, please visit:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Advanced Technology Is Reshaping Medication Safety and Pharmacy Practice
2
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
3
Single Dose of Psilocybin Demonstrates Rapid Relief of Depression Symptoms in Phase 2 Trial
4
How Clinical Pharmacists Optimize Obstructive Hypertrophic Cardiomyopathy Care
5